Ovarian cancer is hard to detect early because symptoms are vague, but treatment for advanced disease has improved meaningfully with PARP inhibitor pills, especially for women with BRCA mutations or other DNA-repair defects. About half of all ovarian cancers carry these features and may benefit.
What's actually going on in research
Studies are testing PARP inhibitor combinations, antibody-drug conjugates that target ovarian-cancer-specific proteins, immunotherapy approaches, and new strategies for platinum-resistant disease. Researchers are also evaluating less-extensive surgery in select patients, maintenance therapy after first response, and screening in women with strong family history.
PARP inhibitor pills
Daily PARP inhibitor pills extend remission for many women, especially those with BRCA mutations or homologous recombination deficiency. Trials are testing combinations to reach more patients.
Antibody-drug conjugates
Targeted antibodies that carry chemotherapy directly to ovarian cancer cells are showing benefit in platinum-resistant disease, where options have been limited.
Genetic testing
All women with ovarian cancer should have tumor and inherited genetic testing, since BRCA and related mutations open doors to specific treatments and affect family members' risk.
What to know before you search
Eligibility often depends on tumor type (high-grade serous most common), stage, prior chemotherapy response, and BRCA or homologous recombination deficiency status.
What types of trials are currently open
- Treatment trials — Testing new drugs or combinations in women with ovarian cancer to see if they extend remission or work in resistant disease.
- Maintenance trials — Testing whether continuing a treatment after chemotherapy keeps the cancer in remission longer.
- Surgical trials — Comparing different surgical approaches, including timing of surgery and extent of tissue removal.
- Screening trials — Testing strategies to detect ovarian cancer earlier, especially in women with family history or BRCA mutations.
- Supportive care trials — Testing ways to manage neuropathy, fatigue, and other side effects of long-term chemotherapy.
Recently added Ovarian Cancer trials
Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory Study
The aim of this study is to investigate the efficacy and safety of enucleation of enlarged CPLNs in patients with advanced ovarian cancer.
Construction of a Multi-dimensional Risk Assessment System: a Clinical Study of Polycystic Ovary Syndrome Complicated With Thrombophilia
This observational case-control study aims to develop a multidimensional risk assessment model for thrombophilia-related abnormalities in females with polycystic ovary syndrome (PCOS). The study will analyze endocrine, metabolic, and genetic factors associated with decreased protein C and/or protein S levels in participants with PCOS. The results are expected to provide evidence for risk stratification and individualized management in this population.
Find Ovarian Cancer trials matched specifically to you
Answer 3 quick questions and we'll show you trials that fit your situation.